Back
Amicus Therapeutics 10K Form
Sell
31
FOLD
Amicus Therapeutics
Last Price:
9.50
Seasonality Move:
24.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2023-11-08 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2023-08-08 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2023-05-10 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2022-11-07 | 10Q | FOLD/Amicus Therapeutics Quarterly |
| 2022-08-04 | 10Q | FOLD/Amicus Therapeutics Quarterly |
Receive FOLD News And Ratings
See the #1 stock for the next 7 days that we like better than FOLD
FOLD Financial Statistics
Sales & Book Value
| Annual Sales: | $399.36M |
|---|---|
| Cash Flow: | $-31.51M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.44 |
| Price / Book: | 21.53 |
Profitability
| EPS (TTM): | -0.49000 |
|---|---|
| Net Income (TTM): | $-147.07M |
| Gross Margin: | $362.03M |
| Return on Equity: | -115.21% |
| Return on Assets: | -19.91% |
Amicus Therapeutics Earnings Forecast
Key Amicus Therapeutics Financial Ratios
- The Gross Profit Margin over the past 21 years for FOLD is 90.65%.
- The Selling, General & Administrative Expenses for FOLD have been equal to 68.93% of Gross Profit Margin.
- The Research & Development expenses have been 38.16% of Revenue.
- The Interest Expense is -33.08% of Operating Income.
- The Net Earning history of FOLD is -37.96% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 11 years.
Amicus Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FOLD |
| CUSIP: | 03152W |
| Website: | amicusrx.com |
Debt
| Debt-to-Equity Ratio: | 2.97 |
|---|---|
| Current Ratio: | 3.03 |
| Quick Ratio: | 2.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 19.34 |
FOLD Technical Analysis vs Fundamental Analysis
Sell
31
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Sell
The current Amicus Therapeutics [FOLD] share price is $9.50. The Score for FOLD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.